PLX8394 Uses, Dosage, Side Effects and more

PLX8394 is under investigation in clinical trial NCT02428712 (A Study of PLX8394 as a Single Agent in Patients With Advanced Unresectable Solid Tumors).

Trade Name PLX8394
Generic PLX8394
Type
Formula C25H21F3N6O3S
Weight Average: 542.54
Monoisotopic: 542.134794223
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share